You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Medtronic
Mallinckrodt
Merck
AstraZeneca

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Patent: 7,914,404

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,914,404
Title:Ball bat including visual indication of whether internal structural tampering with the ball bat has occurred
Abstract: A ball bat includes a barrel having a radially inner surface. Graphics, or an indicator layer including graphics, that provide a visual indication of whether tampering, such as shaving, has occurred to the radially inner surface of the barrel are affixed to, applied to, or integral with the radially inner surface of the barrel. A transparent or translucent cap, or a cap including a window, is optionally attached to an end of the barrel to provide visual inspection of the internal graphics. The cap itself may additionally or alternatively include internal observable features, or external engraved or etched features, that make the cap difficult to replicate or counterfeit.
Inventor(s): Giannetti; William B. (Winnetka, CA), Chauvin; Dewey (Simi Valley, CA), Chuang; Hsing-Yen (Simi Valley, CA)
Assignee: Easton Sports, Inc. (Van Nuys, CA)
Application Number:12/259,087
Patent Claims:see list of patent claims

Details for Patent 7,914,404

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Easton Sports, Inc. (Van Nuys, CA) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Merck
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.